Cookie Preferences
By clicking, you agree to store cookies on your device to enhance navigation, analyze usage, and support marketing. More Info
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Recent research from the Centers for Disease Control and Prevention (CDC) highlights distinct health and social-emotional challenges faced by teens diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). This study, published in the Journal of Developmental and Behavioral Pediatrics, offers critical insights directly from the teens themselves, providing a unique view often missed when relying solely on parent or clinical reports.
Researchers analyzed nationally representative data from July 2021 through December 2022, comparing self-reported experiences of teens aged 12 to 17 with and without ADHD. Approximately 10% of teenagers had an ADHD diagnosis, and the findings reveal specific areas where teens with ADHD face notable difficulties.
Teenagers with ADHD reported significantly higher rates of bullying victimization and struggles in making friends compared to their peers. Surprisingly, they were less likely to report a lack of peer support, suggesting complexities in how they perceive friendships and social networks. The study underscores the importance of directly engaging teens in assessing their social relationships, rather than solely relying on parental perspectives.
Sleep difficulties emerged as another critical issue for teens with ADHD. About 80% reported problems like difficulty waking up and irregular wake times, markedly higher than their non-ADHD counterparts. Such disruptions can exacerbate attention difficulties and emotional regulation issues, further complicating daily life for these teens.
Excessive screen time also stood out, with nearly two-thirds of teens with ADHD spending over four hours daily on screens, excluding schoolwork. This high screen usage is concerning, given its potential negative impact on physical and mental health, including sleep quality and social interactions.
Notably, the study found no significant differences in physical activity levels or concerns about weight between teens with and without ADHD. This finding contrasts with previous studies that have highlighted lower physical activity among children with ADHD, suggesting the need for continued research on how physical activity is measured and encouraged in this population.
The study’s authors emphasize the importance of health promotion interventions tailored specifically for teens with ADHD. By directly engaging teens and considering their unique perspectives, interventions can better address social-emotional well-being and healthy lifestyle behaviors, ultimately improving long-term outcomes for this vulnerable group.
Overall, this research provides compelling evidence for healthcare providers, educators, and families to focus on supporting teens with ADHD in areas of social skills, sleep hygiene, and healthy screen time habits. Such targeted support can significantly enhance the quality of life and health outcomes for adolescents navigating the challenges of ADHD.
Katz, S. M., Claussen, A. H., Black, L. I., Leeb, R. T., Newsome, K., Danielson, M. L., & Zablotsky, B. (2025). Attention-Deficit/Hyperactivity Disorder and Teen Self-Report on Health Behaviors and Social-Emotional Wellbeing: United States, July 2021–December 2022. Journal of Developmental & Behavioral Pediatrics, 46(2), e155–e161. doi:10.1097/DBP.0000000000001350.
Drivers with ADHD are far more likely to be involved in crashes, to be at fault in crashes,to be in severe crashes, and to be killed in crashes. The more severe the ADHD symptoms, the higher the risk. Moreover, ADHD is often accompanied by comorbid conditions such as oppositional-defiant disorder, depression, and anxiety that further increase the risk.
What can be done to reduce this risk? A group of experts has offered the following consensus recommendations:
· Use stimulant medications. While there is no reliable evidence on whether non-stimulant medications are of any benefit for driving, there is solid evidence that stimulant medications are effective in reducing risk. But there is also a rebound effect in many individuals after the medication wears off, in which performance actually becomes worse than if had been prior to medication. It is therefore important to time the taking of medication so that its period of effectiveness corresponds with driving times. If one has to drive right after waking up, it makes sense to take a rapid acting form. The same holds for late night driving that may require a quick boost.
· Use a stick shift vehicle wherever possible. Stick shifts make drivers pay closer attention than automatic transmissions. The benefits in alertness are most notable in city traffic. But using a stick shift is far less beneficial in highway driving, where shifting is less frequent.
· Avoid cruise control. Highways can be monotonous, making drivers more prone to boredom and distraction. That is even more true for those with ADHD, so it is best to keep cruise control turned off.
· Avoid alcohol. Drinking and driving is a bad idea for everyone, but, once again, it's even worse for those with ADHD. Parents should consider a no-questions-asked policy of either picking up their teenager anytime and anywhere, or setting up an account with a ride-sharing service.· Place the smartphone out of reach and hearing. Cell phone use is as about as likely to impair as alcohol. Hands-free devices only reduce this risk moderately, because they continue to distract. Texting can be deadly. Sending a short text or emoticon can be the equivalent of driving 100 yards with one's eyes closed. Either turn on Do Not Disturb mode, or, for even greater effectiveness, place the smart phone in the trunk.
· Make use of automotive performance monitors. These can keep track of maximum speeds and sudden acceleration and braking, to verify that a teenager is not engaging in risky behaviors.
· Take advantage of graduated driver's licensing laws wherever available. These laws forbid the presence of peers in the vehicle for the first several (for example, six) months of driving. Parents can extend that period for teenagers with ADHD, or set it as a condition in states that lack such laws.
· Encourage practicing after obtaining a learner's permit. Teenagers with ADHD generally require more practice than those without. A pre-drive checklist can be a good place to start. For example:check the gas, check the mirrors, make sure the view through the windows is unobstructed, put cell phone in Do Not Disturb mode and place it out of reach, put on seat belt, scan for obstacles.
· Consider outsourcing. Look for a driving school with a professional to teach good driving skills and habits.
Experts do not agree on whether to delay licensing for those with ADHD. On the one hand, teenagers with ADHD are 3-4 years behind in the development of brain areas responsible for executive functions that help control impulses and better guide behavior. Delaying licensing can reduce risk by about 20 percent. On the other hand, teens with ADHD are more likely to drive without a license, and no one wants to encourage that, however inadvertently. Moreover, graduated driver's licensing laws only have legal effect on teens who get their licenses at the customary age.
.png)
A recent Finnish study offers important insights into how symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) in adolescence can shape academic performance, and even influence educational outcomes well into adulthood. Children and teens with ODD often show a pattern of angry, irritable moods, arguing with adults, and defying rules or requests. They may lose their temper easily, be quick to blame others for mistakes, and deliberately annoy people.
The researchers followed participants from the Northern Finland Birth Cohort of 1986, a large, population-based study. They looked at over 6,000 teens whose parents reported symptoms of ADHD and ODD when the children were 15–16 years old. The team then tracked their academic performance at age 16 and their highest level of education by age 32.
ADHD is well-known for affecting school performance, often linked to difficulties with attention, impulse control, and executive functioning. ODD, characterized by patterns of irritability, defiance, and hostility toward authority figures, is less studied in this context, especially when it appears without ADHD.
The study found that both disorders, whether occurring separately or in combination, were associated with poorer grades at age 16. However, teens with ADHD symptoms performed worse than those with only ODD symptoms. Interestingly, students with both ADHD and ODD symptoms had the most pronounced academic struggles, but their performance didn’t significantly differ from the ADHD-only group at that age.
By age 32, the effects were even more striking. Participants with both ADHD and ODD symptoms were the least likely to attend or graduate from higher education institutions. Only about 10% of them reached that level, compared to over 40% of those without these symptoms.
Even after accounting for other influences, such as parental education, family structure, and additional psychiatric conditions, the findings held. This suggests that the combination of ADHD and ODD symptoms in adolescence may uniquely disrupt the educational path.
For adolescent girls with ODD symptoms, the impact was particularly notable: they were significantly more likely to complete only the mandatory nine years of schooling.
These results underscore the lasting effects that behavioral and emotional challenges in adolescence can have. While schools often focus on immediate academic outcomes, this study highlights the importance of early identification and support, not just for ADHD but for ODD as well.
Parents and educators play a crucial role in shaping future outcomes for children and adolescents with ADHD. Recognizing early signs of attention problems, emotional dysregulation, or defiance—and responding with appropriate interventions—could help redirect educational trajectories and open up opportunities down the line.
In short, it’s not just about managing classroom behavior. It’s about supporting long-term potential. When ADHD and ODD symptoms show up in adolescence, they don’t just make school harder—they can limit a student’s entire educational future. Early support and understanding can make a lasting difference.
Attention Deficit Hyperactivity Disorder (ADHD) is a common condition affecting children and adolescents worldwide, characterized by symptoms such as hyperactivity, impulsivity, and inattention. While traditional treatments like medication and behavioral therapy are often used, some individuals are turning to complementary and alternative therapies (CAM) for help. One such option gaining attention is acupuncture. But does it really work for ADHD?
A recent comprehensive study aimed to evaluate the effectiveness of acupuncture in treating ADHD symptoms. Here’s a breakdown of the findings, with a focus on the age groups included in the research and what these findings could mean for ADHD treatment options.
The study in question conducted a systematic review and meta-analysis (SR/MA) of acupuncture trials for ADHD, comparing its effects to traditional treatments such as pharmacotherapy and behavioral therapy. The researchers focused on acupuncture’s impact on core ADHD symptoms like hyperactivity, impulsivity, inattention, and conduct problems, while also exploring how acupuncture might help with other issues, such as learning difficulties and psychosomatic symptoms.
One key feature of this study was the inclusion of a broad age range of participants, specifically children and adolescents. These two groups are the most commonly diagnosed with ADHD, and their responses to treatments can vary significantly. Understanding how acupuncture works for these age groups is critical for evaluating its effectiveness as an ADHD treatment.
Here’s what the study found across the different age groups:
Despite these promising results, the study also highlighted several limitations:
In short, and as is so often the way of evidence-based medicine, we still can’t say with absolute certainty one way or the other. These studies may show promise in improving hyperactivity, impulsivity, inattention, and conduct problems– in both children and adolescents. However, the evidence is not yet strong enough to recommend it as a primary treatment. While it may serve as a helpful complement to standard therapies, especially for those struggling with medication side effects or access to behavioral therapy, more research is needed to establish its effectiveness.
For centuries, we’ve called the eyes the "windows to the soul," but for modern neurologists, they are quite literally a window into the brain. The retina and the central nervous system share the same embryonic origins, developing from the same neural tissue in the womb. Because of this deep biological connection, the back of your eye acts as a non-invasive map of your brain's health, displaying a complex web of nerves and blood vessels that can (theoretically!) mirror certain neurodevelopmental conditions.
Recently, a buzz rippled through the mental health community when a study published in partnership with Seoul National University Bundang Hospital claimed a massive breakthrough. Researchers developed an Artificial Intelligence (AI) model that could screen children for Attention-Deficit/Hyperactivity Disorder (ADHD) using nothing more than a simple retinal photograph. The study, which prospectively recruited children from Severance Hospital and Eunpyeong St. Mary’s Hospital, produced results that were staggering: the AI reportedly achieved an accuracy rate of 96.9%!
In the world of medical testing, scientists use a metric called AUROC (Area Under the Receiver Operating Characteristic) to measure how well a test works.
An AUROC of 96.9% is a near-perfect score, suggesting a tool is ready for immediate, real-world deployment. While headlines promised a revolution in mental health screening, a deeper look into this research and the study’s design has exposed that this 96.9% AUROC was more likely evidence of a flawed methodology rather than a biological reality.
To build their screening tool, researchers analyzed over 1,100 retinal images using a digital pipeline called AutoMorph and a machine-learning model known as XGBoost. The AI was trained to hunt for physical signals of the "Dopamine Connection." Dopamine is the primary neurotransmitter involved in ADHD, but it is also essential to the eye. It regulates synaptic formation, retinal blood flow, and vascular endothelial regulation. Because dopamine dysregulation influences how blood vessels grow and remodel, the study hypothesized that an ADHD brain would leave a unique "fingerprint" on the retinal vasculature, resulting in denser, thicker vessel structures.
On paper, the logic was sound: use AI to spot the subtle vascular remodeling caused by dopaminergic shifts. But a closer look at the investigation revealed that the AI wasn't just spotting ADHD; it was over-indexing on technical noise.
The most significant "smoking gun" flagged by critics is a massive temporal mismatch. In other words, there was a severe disparity in the timeframes and conditions under which the retinal images for the two comparison groups were collected. For an AI to learn a biological condition, it must compare groups under identical technical conditions. Instead, this study created a time-traveling dataset:
A scientific study is only as reliable as its control group. The control in any experiment acts as a baseline against which the study group is compared. In this case, the control group should be composed of children without any neurodevelopmental disorders, or of “typically developing” children.
In this study, the control group wasn't composed of healthy children from the community. Instead, they were patients visiting a tertiary ophthalmology clinic. Children visiting a specialist eye hospital are rarely "typical." They are there because they have symptomatic eye issues. This introduced a massive selection bias involving three major confounders:
When training AI, you must never allow the "test questions" to leak into the "study material." The researchers, however, committed a fundamental violation of machine learning hygiene known as Eye-to-Eye Data Leakage. The study split the data by the eye rather than by the participant.
Human eyes are highly correlated; the left eye is a near-mirror of the right. If a child's left eye was used for training and their right eye was used for testing, the AI was effectively "cheating." Instead of learning the general traits of ADHD, the model was potentially memorizing individuals. This error artificially balloons accuracy metrics.
The true test of medical AI is diagnostic specificity, or differential diagnosis. This refers to the ability to tell one condition apart from another. While the model claimed 96.9% accuracy against a flawed control group, its performance collapsed when faced with real-world complexity.
When the researchers asked the AI to differentiate between ADHD and Autism Spectrum Disorder (ASD), the accuracy plummeted to a poor 63% AUROC. In real-world clinical settings, an accuracy of 63% is dangerously close to a 50% coin flip. Since ADHD frequently co-occurs with ASD, anxiety, or intellectual disabilities, an AI that cannot handle these "clinical differentials" is functionally useless in a doctor's office. The failure at this stage proves the model was likely detecting technical quirks of the dataset rather than a unique biological marker for ADHD.
To move from the lab to the clinic, we must establish a foundation built on rigor rather than high-speed data scraping. Moving forward, we must demand these 3 Pillars of Trusted Medical AI :
The dream of a quick eye scan to diagnose ADHD is not dead, but it must be rescued from "fast science" shortcuts and buzzy headlines.
Background:
One of the more persistent concerns among parents of children with ADHD is whether stimulant medications will stunt their child's growth. A large Israeli cohort study now offers some of the most rigorous reassurance to date, and its methodology sets it apart from earlier research.
The question has long been complicated by a more fundamental uncertainty: do growth differences in children with ADHD stem from the condition itself, from stimulant treatment, or from factors present before any medication is ever prescribed? Without a clear answer, clinicians and families have faced a genuine dilemma when weighing the benefits of stimulant therapy against potential long-term physical costs.
Most previous studies compounded this difficulty by comparing group-average heights, which ignores the crucial variable of genetic potential. A child who is short relative to the general population may simply have short parents. Failing to account for this introduces systematic bias and can make medications appear more harmful than they are.
The Study:
The Israeli research team addressed this directly. Using health records from a nationwide provider, they assembled a retrospective cohort of children born between 1995 and 2003, following them through 2023. This amount of time was long enough for all participants to have reached adult stature (defined as 17 or older for females, 19 or older for males). Their sample included 5,671 children with untreated ADHD, 11,846 who received stimulant treatment, and 47,258 non-ADHD controls. Children who took stimulants for only one to two months, or who had chronic medical conditions requiring long-term medication, were excluded to avoid confounding the results.
Crucially, adult height was evaluated not against population norms but against each individual's expected height, calculated from parental heights using the Tanner-Goldstein-Whitehouse method, a standard approach for estimating genetic height potential via mid-parental height.
When the researchers compared adult heights across the three groups using analysis of variance (ANOVA), they did find statistically significant differences. But statistical significance, particularly in studies with tens of thousands of participants, does not automatically translate into clinical significance. The effect sizes were consistently very small, and the absolute differences were under one centimeter, which is a margin considered clinically negligible.
Their conclusion is measured but clear: after accounting for genetic growth potential, neither an ADHD diagnosis nor stimulant treatment was associated with meaningful reductions in adult height. The findings, they argue, support prioritizing behavioral and functional outcomes when making treatment decisions, since the risk of clinically significant height loss appears to be minimal.
The Take-Away:
For families navigating ADHD treatment, the practical implication is significant: concerns about permanent growth suppression, while understandable, should not be the primary driver of whether or how long a child receives stimulant therapy.
A recent meta-analysis examined how well cognitive behavioral therapy (CBT) improves not just symptoms, but everyday functioning and quality of life in adults with ADHD.
The Background:
ADHD in adults affects far more than attention or impulsivity. It often disrupts key areas of life:
These broad impacts highlight a key issue: reducing symptoms does not automatically translate into better day-to-day functioning.
CBT is a structured, skills-based therapy that helps people:
While both medication (especially stimulants) and CBT improve core ADHD symptoms, CBT is particularly aimed at improving real-world functioning.
The Study:
The researchers analyzed studies involving adults diagnosed with ADHD (or showing clinically significant symptoms). They included:
They focused specifically on outcomes beyond symptoms:
The Results:
1. Strongest Effects: Occupational functioning
CBT showed consistently strong improvements in work-related functioning compared to control groups, both immediately after treatment and at follow-up. This was the most robust finding across domains.
2. Moderate Improvement: Global Functional Impairment
CBT led to moderate improvements in overall daily functioning, with some evidence that gains persist over time. In studies tracking individuals over time, improvements were even stronger at follow-up.
3. Modest Gains: Social Relationships
CBT produced small to moderate improvements in social functioning. Benefits were present both after treatment and at follow-up, but were less pronounced than in work-related outcomes.
4. Limited Effects: Academic Functioning
There were moderate short-term gains when CBT was compared to control groups, but these did not persist at follow-up. Within-subject studies showed only small improvements overall.
5. Modest and Inconsistent Effects: Quality of Life
Improvements in quality of life were small when compared to control groups and often did not last. However, studies tracking individuals over time showed moderate improvements, suggesting some benefit that may not always show up clearly in between-group comparisons.
Overall, the findings suggest:
One notable nuance: CBT did not always outperform other active treatments (like medication or other therapies). This suggests that while CBT is effective, its benefits may partly overlap with broader therapeutic or support effects rather than relying on a single, unique mechanism.
The Take-Away:
CBT is a valuable, evidence-based treatment for adults with ADHD, especially for improving work functioning and overall daily life management. However, its impact on relationships, academic outcomes, and quality of life is more limited and less consistent, pointing to the need for more targeted or combined approaches in those areas.
_logo%201.svg)
